申请人:Hashimoto Noriaki
公开号:US08367708B2
公开(公告)日:2013-02-05
The present invention relates to a compound represented by formula (I), which has a GPR120 agonist action and thus is useful for treatment of diabetes mellitus or hyperlipidemia, or a pharmaceutically acceptable salt thereof. In the formula, (AA) represents a phenyl or the like, which may be substituted with a lower alkoxy group or the like; (BB) represents a divalent group or the like, derived by removal of two hydrogen atoms from a benzene which may be substituted with a halogen atom or the like; X represents a spacer having a main chain composed of 1-8 carbon atoms wherein 1-3 carbon atoms in the main chain may be substituted with an oxygen atom or the like; and Y represents a hydrogen atom or the like.
本发明涉及一种由式(I)表示的化合物,其具有GPR120激动剂作用,因此对治疗糖尿病或高脂血症有用,或其药学上可接受的盐。在该式中,(AA)表示苯基或类似物,它可以用较低的烷氧基或类似物替代; (BB)表示二价基团或类似物,由苯环中去除两个氢原子而来,该苯环可以用卤原子或类似物替代; X表示具有由1-8个碳原子组成的主链的间隔物,其中主链中的1-3个碳原子可以用氧原子或类似物替代; Y表示氢原子或类似物。